COVID-19 vaccines

[1]  E. Guenova,et al.  Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience , 2022, World Allergy Organization Journal.

[2]  A. Gundlapalli,et al.  Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 , 2021, MMWR. Morbidity and mortality weekly report.

[3]  A. Nagy,et al.  An overview of current COVID-19 vaccine platforms , 2021, Computational and Structural Biotechnology Journal.

[4]  O. Tomori,et al.  Ebola virus disease: current vaccine solutions. , 2021, Current opinion in immunology.

[5]  Hannah Ritchie,et al.  A global database of COVID-19 vaccinations , 2021, Nature Human Behaviour.

[6]  M. Sockrider,et al.  What Are COVID-19 Vaccines? , 2021, American journal of respiratory and critical care medicine.

[7]  M. Yousef,et al.  Super-rapid race for saving lives by developing COVID-19 vaccines , 2021, J. Integr. Bioinform..

[8]  H. Ellis.  James Phipps, first to be vaccinated against smallpox by Edward Jenner , 2020, Journal of perioperative practice.

[9]  A. Rodríguez-Morales,et al.  SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic , 2020, Annals of clinical microbiology and antimicrobials.

[10]  V. Shinde,et al.  Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine , 2020, The New England journal of medicine.

[11]  Ilya J. Finkelstein,et al.  Structure-based design of prefusion-stabilized SARS-CoV-2 spikes , 2020, Science.

[12]  C. Foged,et al.  The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies , 2020, Frontiers in Immunology.

[13]  Xiangxi Wang,et al.  Development of an inactivated vaccine candidate for SARS-CoV-2 , 2020, Science.

[14]  Ewen Callaway,et al.  The race for coronavirus vaccines: a graphical guide , 2020, Nature.

[15]  W. Ni,et al.  Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 , 2020, Journal of Microbiology, Immunology and Infection.

[16]  Lanjuan Li,et al.  SARS-CoV-2: virus dynamics and host response , 2020, The Lancet Infectious Diseases.

[17]  A. Wiyeh,et al.  A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus , 2020, Human vaccines & immunotherapeutics.

[18]  S. Sell.  How vaccines work: immune effector mechanisms and designer vaccines , 2019, Expert review of vaccines.

[19]  Edith Jasny,et al.  New Vaccine Technologies to Combat Outbreak Situations , 2018, Front. Immunol..

[20]  P. Alves,et al.  Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology , 2015, Biotechnology journal.

[21]  S. Perlman,et al.  Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein , 2013, Journal of Virology.

[22]  T. Barbosa,et al.  Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[23]  COVID-19: Epidemiology, virology, and prevention , 2021 .

[24]  H. Branswell.  A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines , 2020 .

[25]  D. Wood.  New vaccine technologies. , 2002, Developments in biologicals.